Study Reveals Women Face Longer Delays in Autoimmune Diagnosis
Research shows women with autoimmune diseases often experience misdiagnosis and longer wait times for accurate diagnosis compared to men.
Women wait longer for autoimmune disease diagnoses than men.
43% of women report symptoms attributed to mental health issues.
Medical gaslighting may contribute to diagnostic delays for women.
A recent international study has highlighted significant disparities in the diagnosis of autoimmune diseases between genders, revealing that women often face longer delays and are more likely to be misdiagnosed. Conducted between December 2024 and March 2025, the research surveyed over 6,600 adults suffering from conditions like lupus and rheumatoid arthritis, with a majority of participants being women from the UK.
The findings indicate that while 50% of men received their diagnosis within the first year of symptom onset, only 40% of women experienced the same promptness. Furthermore, women reported being told their symptoms were psychosomatic or linked to mental health issues at higher rates than men. Specifically, 43% of women compared to 33% of men had their symptoms attributed to mental health conditions, and 34% of women were labeled as psychosomatic versus 22% of men. Additionally, women were more likely to wait four years or more for a diagnosis and to see a clinician 11 or more times before receiving a correct diagnosis.
The lead author of the study, Dr. Melanie Sloan from the University of Cambridge, expressed concern over the high rates of misdiagnosis among women, emphasizing that these disparities persist even after accounting for variables such as age and type of disease. The study raises questions about the phenomenon of medical gaslighting, where patients feel their symptoms are dismissed or attributed to psychological causes rather than being taken seriously as physical ailments.
The implications of these findings are significant, particularly for public health and medical practice. The study suggests that healthcare providers may hold biases that affect their diagnostic processes, leading to women receiving less timely care for conditions that disproportionately affect them. This could result in prolonged suffering and complications for women with autoimmune diseases, highlighting the need for improved awareness and training among healthcare professionals.
Looking ahead, the study calls for further research to explore the reasons behind these gender disparities in diagnosis. It also urges healthcare providers to adopt more inclusive practices that consider the unique experiences of women in the diagnostic process. Patients are encouraged to advocate for themselves and seek second opinions if they feel their concerns are not being adequately addressed.
